Trial Profile

Long-Term Follow-Up of Hospitalized Dengue and Safety in Thai Children Who Were Included in an Efficacy Study of a Tetravalent Dengue Vaccine

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Apr 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

04 Apr 2021 Results of post-hoc analysis assessing hospitalized and severe VCD cases over the entire six-year follow-up of (two Phase III trials (CYD14 [NCT01373281] and CYD15 [NCT01374516]) and the Phase IIb trial (CYD23/CYD57 [NCT00842530/NCT01983553]) published in the Clinical Infectious Diseases
13 Jun 2018 Results of post-hoc analysis assessing effect of dengue serostatus on vaccine safety and efficacy by using data from four trials including this trial published in the New England Journal of Medicine.
27 Sep 2016 Status changed from active, no longer recruiting to completed.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com